Clinical Trial Update: A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the safety and effectiveness of rabeprazole for treating gastroesophageal reflux disease in pediatric patients has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (AcipHex) (rabeprazole)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 3 | Status: COMPLETED | Results posted: 2012-10-11